Cellectis (LTS:0WA2) Days Sales Outstanding : 61.93 (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cellectis Days Sales Outstanding?

Cellectis's average Accounts Receivable for the three months ended in Dec. 2024 was €8.24 Mil. Cellectis's Revenue for the three months ended in Dec. 2024 was €12.15 Mil. Hence, Cellectis's Days Sales Outstanding for the three months ended in Dec. 2024 was 61.93.

The historical rank and industry rank for Cellectis's Days Sales Outstanding or its related term are showing as below:

LTS:0WA2' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.07 Med: 59.92 Max: 329.92
Current: 77.59

During the past 13 years, Cellectis's highest Days Sales Outstanding was 329.92. The lowest was 30.07. And the median was 59.92.

LTS:0WA2's Days Sales Outstanding is ranked worse than
53.58% of 853 companies
in the Biotechnology industry
Industry Median: 72.84 vs LTS:0WA2: 77.59

Cellectis's Days Sales Outstanding declined from Dec. 2023 (156.18) to Dec. 2024 (61.93).

Cellectis Days Sales Outstanding Historical Data

The historical data trend for Cellectis's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellectis Days Sales Outstanding Chart

Cellectis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

30.07

151.34

189.07

329.92

31.93

Cellectis Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															156.18	167.29	145.01	59.77	61.93

Competitive Comparison of Cellectis's Days Sales Outstanding

For the Biotechnology subindustry, Cellectis's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellectis's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectis's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cellectis's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Cellectis Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cellectis's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0.522	+	6.412)	/	2 )	/	39.638	*	365
=	3.467					/	39.638	*	365
=	31.93

Cellectis's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (10.073	+	6.412)	/	2 )	/	12.145	*	365 / 4
=	8.2425					/	12.145	*	365 / 4
=	61.93

Cellectis (LTS:0WA2) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cellectis Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cellectis's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellectis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (LTS:0WA2) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CLLS:USA ALCLS:France ZVAA:Germany

Address

8, rue de la Croix Jarry, Paris, FRA, 75013

Website

https://www.cellectis.com

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Cellectis Headlines

No Headlines